The effect of weight loss on serum concentrations of nitric oxide, TNF-α and soluble TNF-α receptors

Endokrynologia Polska

Volumn 57, Issue 5, 2006, Pages 487-493

  Olszanecka Glinianowicz, Magdalena ^a   Zahorska Markiewicz, Barbara ^a   Janowska, Joanna ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Nitric oxide; Soluble TNF receptors; TNF ; Weight loss

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; BLOOD; BODY COMPOSITION; BODY MASS; BODY WEIGHT; DIET THERAPY; FEMALE; HUMAN; LOW CALORY DIET; MIDDLE AGED; OBESITY; PHYSIOLOGY; WEIGHT REDUCTION;

ADULT; BIOLOGICAL RESPONSE MODIFIERS; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; DIET, REDUCING; FEMALE; HUMANS; MIDDLE AGED; NITRIC OXIDE; OBESITY; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

EID: 35448978177     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Valet P, Tavernier G, Castan-Laurell I et al. Understanding adipose tissue development from transgenic animal models. J Lipid Res 2002; 43: 835-860.
2. Arner P. Hunting for human obesity genes? Look in the adipose tissue! Intern J Obes Relat Metab Disord 2000; 24 (supl. 4): 57-62.
3. Bouchard C, Despres JP, Mauriege P. Genetic and nongenetic determinants of regional fat distribution. Endocrine Rev 1993; 14: 72-93.
4. Frühbeck G, Gomez-Ambrosi J, Muruzàbal FJ et al. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 2001; 280: 827-847.
5. Summers SA, Whiteman EL, Birnbaum MJ. Insulin signaling in the adipocyte. Intern J Obes Relat Metab Disord 2000; 24 (supl. 4): 67-70.
6. Gaudiot N, Jaubert AM, Charbonnier E et al. Modulation of white adipose tissue lipolysis by nitric oxide. J Biol Chem 1998; 273: 13 475-13 481.
7. Jordan J, Tank J, Stoffels M et al. Interaction between b-adrenergic receptor stimulation and nitric oxide release on tissue perfusion and metabolism. J Clin Endocrinol Metab 2001; 86: 2803-2810.
8. Elizalde M, Ryden M, van Harmelen V et al. Expresion of nitric oxide synthases in subcutaneous adipose tissue of nonobese and obese humans. J Lipid Res 2000; 41: 1244-1251.
9. Choi J.W, Pai SH, Kim SK et al. Increases in nitric oxide concentrations correlate strongly with body fat in obese humans. Clin Chem 2001; 47: 1106-1109.
10. Olszanecka-Glinianowicz M, Zahorska-Markiewicz B, Janowska J et al. Serum concentrations of nitric oxide, TNF-α and TNF soluble receptors in women with overweight and obesity. Metabolism 2004; 53: 1268-1273.
11. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
12. Stephens JM, Pekala PH. Transcriptional repression of GLUT-4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-a. J Biol Chem 1992; 266: 21 839-21 845.
13. Zhang B, Berger J Hu E et al. Negative regulation of peroxisome proliferators-activated receptor - gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-α. Mol Endocrinol 1996; 10: 1457-1466.
14. Mohamed-Ali V, Goodrick S, Rawesh A et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-a, in vivo. J Clin Endocrinol Metab 1997; 82: 4196-4200.
15. Zahorska-Markiewicz B, Janowska J, Olszanecka-Glinianowicz M et al. Serum concentrations of tumor necrosis factor in obese women. J Endocrinol Invest 1999; 22 (supl. 7): S66.
16. Zahorska-Markiewicz B, Janowska J, Olszanecka-Glinianowicz M et al. Serum concentrations of TNF-α and soluble TNF-α receptors in obesity. Intern J Obes Relat Metab Disord 2000; 24: 1392-1395.
17. Diez-Ruiz A, Tilz GP, Zangerle R et al. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur J Hematol 1995; 54: 1-8.
18. Hauner H, Bender M, Haastert B et al. Plasma concentrations of soluble TNF-α receptors in obese subjects. Intern J Obes Relat Metab Disord 1998; 22: 1239-1243.
19. Kern PA, Saghizadeh M, Ong JM et al. The expression of tumor necrosis factor in human adipose tissue regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995; 95: 2111-2119.
20. Bruun JM, Pedersen SB, Kristensen K et al. Opposite regulation of interleukin-8 and tumor necrosis factor-α by weight loss. Obes Res 2002; 10: 499-506.
21. Winkler G, Kiss S, Kesztheleyi L et al. Expression of tumor necrosis factor (TNF)- α protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-α, soluble serum TNF-receptor-2 concentrations and C-peptide level. Eur J Endocrinol 2003; 149: 129-135.
22. Olszanecka-Glinianowicz M, Zahorska-Markiewicz B, Janowska J et al. Serum concentrations of tumor necrosis factor TNF-α and its soluble receptors in obese women with insulin resistance. Polish J Endocrinol 2003; 54: 414-420.
23. Olszanecka-Glinianowicz M, Zahorska-Markiewicz B, Janowska J et al. The effect of weight loss on serum concentrations of tumor necrosis factor TNF, soluble receptors TNF and insulin resistance. Polish J Endocrinol 2004; 55: 182-188.
24. Kern PA, Saghizadeh M, Ong JM et al. The expression of tumor necrosis factor in human adipose tissue regulation by obesity, weight loss and relationship to lipoprotein lipase. J Clin Invest 1995; 95: 2111-2119.
25. Hotamisligil GS, Arner P, Atkinson RL et al. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes 1997; 46: 451-455.
26. Fernandez-Real JM, Broch M, Ricart W et al. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes 1998; 47: 1757-1762.